Comparable and high THC-to-CBD ratio products may result in small improvements in pain and increase in common adverse events.

NMRA-511 showed promising results in Phase 1b study for Alzheimer's disease agitation with favorable tolerability and safety ...

Cyril Z. used a powerful sedative to render his victims semi-conscious before filming himself raping them. Despite complaints ...

Neumora Therapeutics (NMRA) announced results from its Phase 1b signal-seeking study of NMRA-511 in people with Alzheimer’s disease agitation.

Apex Endodontic Studio announced today the launch of its newly redesigned website, The new site reflects the practice's ...

NMRA-511 demonstrated a 15.7 reduction on mean CMAI total score, representing a clinically meaningful effect NMRA-511 demonstrated unsurpassed ...

NMRA-511 demonstrated a 15.7 reduction on mean CMAI total score, representing a clinically meaningful effect NMRA-511 demonstrated unsurpassed clinical effect size on CMAI total score in a pre-specifi ...